Tag: stroke treatments
European Stroke Awareness Day: Persistent disparities require “urgent attention” despite recent...
As per data from the Stroke Services Tracker (SST)—a monitoring tool developed to evaluate progress towards Stroke Action Plan for Europe (SAP-E) targets—improvements are...
Simona Sacco
Fuelled by a passion for research, and inspired by a “heartbreaking” case she encountered early on in her career, Simona Sacco (L’Aquila, Italy) has...
“We can’t afford to wait”—new coalition calls for urgent action to...
The “world’s first” multisector advocacy movement dedicated to stroke—the Global Stroke Action Coalition—is launching today, and has issued an urgent call to action to...
New data presented at ISC 2025 further validate treatment impact of...
Brainomix will be unveiling a series of new studies this week at the International Stroke Conference (ISC; 5–7 February, Los Angeles, USA), further validating...
Ox-01 neuroprotective candidate selected for evaluation in new US NINDS programme
FreeOx Biotech has announced that its uric acid-based leading compound, Ox-01, has been officially selected by the US National Institute of Neurological Disorders and...
Stroke thrombectomy: Limitless potential or a success story nearing its final...
Mechanical thrombectomy has gone from strength to strength in the treatment of acute ischaemic stroke over the past decade—progressing beyond early-window large vessel occlusions...
Every hour saved between stroke onset and thrombectomy could equate to...
A systematic review and meta-analysis of five studies and more than 11,000 patient records has indicated that each hour saved between acute ischaemic stroke...
Philips and Medtronic partner to help accelerate access to life-saving stroke...
Royal Philips and Medtronic Neurovascular today announced a strategic advocacy partnership that will see the two companies attempt to raise awareness around potential health...
Ten years of MR CLEAN: Stroke thrombectomy’s evolution and ongoing challenges
This year, 25 October marks a full decade since the initial presentation of results from the MR CLEAN randomised controlled trial (RCT), which—along with...
US Medicare “continues to undervalue” stroke thrombectomy, new research shows
Despite mechanical thrombectomy’s high success rate in saving the lives of stroke patients, Medicare is paying lower rates over time for the procedure in...
Researchers highlight potential for autonomous stroke thrombectomy treatments in new paper
The use of robots in the autonomous treatment of stroke patients could widen access to time-sensitive emergency mechanical thrombectomy procedures, as evidenced by a...
New Siemens-WSO partnership to tackle stroke’s “disastrous disease trajectory”
Siemens Healthineers and the World Stroke Organization (WSO) have announced a two-year partnership to develop the acute stroke workforce, and improve treatment and care...
Ischaemic stroke—we are all vulnerable
Conrad Yiu, a pioneer and visionary in interventional ischaemic stroke therapy, passed away in the final weeks of 2023, succumbing to the very disease for...
Apotransferrin shows promise in animal models of intracranial haemorrhage
Researchers from Germans Trias i Pujol Research Institute (IGTP; Badalona, Spain) have discovered that administering human apotransferrin to mice affected by intracranial haemorrhage (ICH)...
Patients in lower socioeconomic status areas less likely to receive acute...
People who live in neighbourhoods with lower socioeconomic status are less likely to receive clot-busting medications or undergo mechanical thrombectomy procedures after they have...
Anaconda Biomed granted additional patents for novel stroke thrombectomy technology
Anaconda Biomed has announced that the European Patent Office has granted the company a European patent for “A device and a thrombectomy apparatus for...
WSO predicts 50% more deaths unless “catastrophic” gaps in global stroke...
Between now and 2050—unless “urgent action is taken”—the number of people who die from stroke globally is estimated to increase by 50%, to 9.7...
Imperative unveils new company structure intended to elevate stroke and vascular...
Imperative Care has announced a new organisational structure designed to accelerate the company’s growth across its businesses. As per an Imperative press release, this...
Artiria granted US FDA clearance for real-time, deflectable guidewire
Artiria Medical, a Swiss neurovascular company, has announced that its real-time, deflectable guidewire has been granted 510(k) clearance by the US Food and Drug...
New WIST guidelines seek to improve access and standardise training in...
A new set of guidelines intended to standardise and expand stroke thrombectomy training have been published simultaneously in Europe, in the journal Advances in...
Uric acid-based neuroprotective agent demonstrates promise in large animal study
The opening day of the 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) saw the presentation of findings from an animal-model study that...
ISC 2023 sees presentation of positive data on new stroke drugs...
New data pointing to the possible advantages held by several drug products in treating acute ischaemic stroke were delivered at the recent International Stroke...
Neuroprotection “renaissance” offers hope for improved stroke therapies in future
The “renaissance” of neuro- and cerebroprotective paradigms, coupled with “the advent of new ideas”—such as the concept of ‘transient neuroprotection’ to preserve the penumbra—appears...
Increased annual stroke rate in Canada underscores need for strong treatments...
A new study funded by the Heart and Stroke Foundation has revealed that annual stroke occurrence rates in Canada have increased to 108,707—roughly one every five minutes. This...
Clinicians urge Scottish government to reverse £7 million thrombectomy funding cut
Health charities and National Health Service (NHS) clinicians have united in a call for the Scottish government to reverse a cut to the funding...
AHA statement highlights need for more data on sex differences in...
A new American Heart Association (AHA) scientific statement has highlighted the need for more data about sex differences in the use of and response...
Why robotics holds the key to the future of stroke treatment
Vitor Pereira and Nicole Cancelliere (St Michael’s Hospital, Toronto, Canada) outline recent breakthroughs in the deployment of robotics for neurointerventional procedures and discuss future...
Route 92 Medical announces first patient enrolment in SUMMIT MAX pivotal...
Route 92 Medical has announced the first patient enrolment in its SUMMIT MAX clinical trial—a randomised, controlled, multicentre study to evaluate the performance of...
AURORA: Evidence in favour of thrombectomy beyond six hours strengthened by...
Evidence favouring endovascular therapy (EVT) in anterior circulation stroke patients presenting with reversible cerebral ischaemia in the later time window (beyond six hours) from...
Rapid Medical to initiate trial expanding thrombectomy treatment across distal regions...
Rapid Medical today announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for what it claims is the first ever trial...
New study finds e-Stroke software shortens treatment times and improves functional...
A new study presented at the 13th World Stroke Congress (WSC 2021; 28–29 October, virtual) found that the implementation of Brainomix's e-Stroke software resulted in...
World Stroke Day 2021: Survey finds 65% of hospitals worldwide do...
On the eve of World Stroke Day (29 October), the World Stroke Organization (WSO) has called for urgent improvements to the treatment of stroke...
North Carolina updates stroke triage and transport protocol
North Carolina has updated its emergency stroke care protocol—a move applauded by the Get Ahead of Stroke campaign. The protocol, which went into effect...
Imperative Care enrols first patient in trial evaluating Zoom 88 Large...
Imperative Care has announced that the first patient has been enrolled in the Imperative trial. This prospective, multicentre clinical trial is the first study...
LINNC 2021: ESCAPE-NEXT trial may bring “dream” of combining neuroprotection with...
At this year’s LINNC Paris Course (14–16 September, Paris, France and virtual), audiences heard that the ESCAPE-NEXT trial (sponsored by NoNO Inc.), which has already started enrolling...
Flying intervention teams lead to higher EVT rates and reduced time...
Flying teams of interventionists directly to a primary stroke centre to perform endovascular therapy (EVT)—as opposed to waiting for the patient to be transferred...
Philips enrols first patient in WE-TRUST stroke study to assess new...
Royal Philips has announced that the first patient has been enrolled in the WE-TRUST (Workflow optimisation to reduce time to endovascular reperfusion for ultra-fast...
Robocath, Rennes University Hospital partner with Philips France to research stroke...
Robocath and Rennes University Hospital have announced they are launching a co-development research programme using robotics to improve treatments for stroke patients. With the...
